Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Susan Markus"'
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-18 (2022)
Abstract Early detection of sheep pregnancy and the prediction of how many lambs a pregnant ewe delivers affects sheep farmers in a number of ways, most notably with regard to feed management, lambing rate, and sheep/lamb health. The standard practic
Externí odkaz:
https://doaj.org/article/c6047f15eb2c4ed08a2ef254c7ffb138
Autor:
Susan Markus, An Chi Guo, Zhiquan Wang, Manoj Kumar Rout, Graham Plastow, Seyed Ali Goldansaz, David S. Wishart, Mark V. Berjanskii
Publikováno v:
J Anim Sci
Mutton and lamb sales continue to grow globally at a rate of 5% per year. However, sheep farming struggles with low profit margins due to high feed costs and modest carcass yields. Selecting those sheep expected to convert feed efficiently and have h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b79b7bada09c8f0aa958857c361ca5
https://europepmc.org/articles/PMC7751155/
https://europepmc.org/articles/PMC7751155/
Autor:
Francisco Rios, Susan Markus
Publikováno v:
Routledge international handbook of multicultural education research in Asia Pacific ISBN: 9781351179959
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e90e0994dd716527901ea0fc8008e3d
https://doi.org/10.4324/9781351179959-4
https://doi.org/10.4324/9781351179959-4
Autor:
Lee M. Krug, Maria Catherine Pietanza, Naoko Takebe, Rosalyn A. Juergens, Mark G. Kris, Sara Subzwari, Naiyer A. Rizvi, Andrew Brown, William D. Travis, Paul K. Paik, Leonard James, Charles M. Rudin, Michelle S. Ginsberg, Susan Markus, Leslie B. Tyson
Publikováno v:
Lung Cancer. 74:481-485
We previously reported data on the safety, tolerability, and recommended phase II dose of obatoclax mesylate in conjunction with topotecan in patients with advanced solid tumor malignancies. Preliminary efficacy data suggested activity in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b31cf5a5e55ed8ad4b1e121b90bc91dd
https://doi.org/10.1016/j.lungcan.2011.05.005
https://doi.org/10.1016/j.lungcan.2011.05.005
Autor:
Susan Markus, Francisco Rios
Publikováno v:
Multicultural Education Review. 3:1-35
This paper explores the various ways scholars in the field have framed the need for multicultural education. These include changing demographics and closing the academic gap, developing cross-cultural competence, confronting colonization and cultural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9a78cc2102f992ed24781d7425a80b8
https://doi.org/10.1080/23770031.2009.11102882
https://doi.org/10.1080/23770031.2009.11102882
Autor:
Sara Subzwari, Michelle S. Ginsberg, Rosalyn A. Juergens, Leonard James, Susan Markus, William D. Travis, Lee M. Krug, Andrew Brown, Leslie B. Tyson, Naiyer A. Rizvi, Mark G. Kris, Charles M. Rudin, Naoko Takebe, Paul K. Paik
To establish the safety, maximum tolerated dose (MTD), recommended phase II dose, and preliminary antitumor activity of obatoclax mesylate (GX15-070MS), a Bcl-2 antagonist, in combination with topotecan in patients with solid tumor malignancies.Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdeb1527204bbbd3c78737cdb089e62
https://europepmc.org/articles/PMC2945625/
https://europepmc.org/articles/PMC2945625/
Autor:
Marianna Zahurak, Ralph Zinner, Nicholas Papadopoulos, Michelle A. Rudek, Steven I. Sherman, David Cosgrove, Nilofer S. Azad, Jing Gong, Shabina Ahmed, Ashley O'Conner, Razelle Kurzrock, Susan Markus, Barry D. Nelkin, Gerald S. Falchook, Douglas W. Ball, Filip Janku, Breelyn A. Wilky
Publikováno v:
Molecular Cancer Therapeutics. 12:B279-B279
Background: P is a small molecule tyrosine kinase inhibitor that selectively inhibits VEGFR1-3, PDGFR-α, PDGFR-β, c-kit, and FGFR 1-3 and is approved for renal cancer and STS. T is a potent, highly selective, allosteric inhibitor of MEK1/2 approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d802d4b50ece8fa4be965066cf7c4bc
https://doi.org/10.1158/1535-7163.targ-13-b279
https://doi.org/10.1158/1535-7163.targ-13-b279
Autor:
Filip Janku, Barry D. Nelkin, Michael A. Carducci, Daniel Finkelstein, Susan Markus, Steven I. Sherman, David Cosgrove, Marianna Zahurak, Douglas W. Ball, Shabina Roohi Ahmed, Melinda Downs, Razelle Kurzrock, Michelle A. Rudek, Ashley O'Connor, Jing Gong, Nilofer S. Azad
Publikováno v:
Journal of Clinical Oncology. 30:TPS3117-TPS3117
TPS3117 Background: Mutations of the RAS/RAF/MEK/ERK signaling pathway, especially RAS, BRAF and IGF-I/II receptor genes play a critical role in the development of many different types of cancers, including breast, colorectal, melanoma, NSCLC, and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5be96540c15580f655bb3f222272d4b7
https://doi.org/10.1200/jco.2012.30.15_suppl.tps3117
https://doi.org/10.1200/jco.2012.30.15_suppl.tps3117
Autor:
Leonard James, William D. Travis, Charles M. Rudin, Susan Markus, S. Subzwari, Naoko Takebe, A. B. Brown, Naiyer A. Rizvi, Leslie B. Tyson, Lee M. Krug
Publikováno v:
Journal of Clinical Oncology. 27:3504-3504
3504 Background: Bcl-2 is a rational target in SCLC since it is overexpressed in 60%-90% of tumors and may play a role in resistance of SCLC to chemotherapy. Obatoclax is a small molecule BH3 mimetic that blocks bcl-2 binding to proapoptotic family m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8382e6b688246bcbf806675b59193047
https://doi.org/10.1200/jco.2009.27.15_suppl.3504
https://doi.org/10.1200/jco.2009.27.15_suppl.3504